Ruane, Cunniff & Goldfarb’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169M Sell
2,353,300
-71,710
-3% -$6.75M 2.63% 17
2026
Q1
$287M Buy
+2,425,010
New +$300M 4.76% 10
2016
Q2
Sell
-126,783
Closed -$5.62M 132
2016
Q1
$5.62M Sell
126,783
-24,754
-16% -$1.05M 0.04% 62
2015
Q4
$7.26M Sell
151,537
-4,557
-3% -$206K 0.04% 61
2015
Q3
$6.43M Buy
156,094
+4,945
+3% +$229K 0.03% 63
2015
Q2
$7.29M Buy
151,149
+11,213
+8% +$535K 0.03% 65
2015
Q1
$6.48M Sell
139,936
-33,487
-19% -$1.51M 0.03% 66
2014
Q4
$7.46M Buy
173,423
+101
+0.1% +$4.1K 0.04% 67
2014
Q3
$6.4M Sell
173,322
-240
-0.1% -$8.22K 0.03% 69
2014
Q2
$5.6M Buy
173,562
+9
+0% +$276 0.03% 76
2014
Q1
$5.02M Sell
173,553
-420
-0.2% -$12.8K 0.03% 69
2013
Q4
$5.69M Hold
173,973
0.03% 66
2013
Q3
$5.41M Buy
173,973
+153,929
+768% +$4.72M 0.03% 71
2013
Q2
$619K Buy
+20,044
New +$649K ﹤0.01% 106

Other funds holding ZTS

Ruane, Cunniff & Goldfarb's ZTS Position: Q2 2026 in Review

Ruane, Cunniff & Goldfarb reduced its Zoetis (ZTS) stake by 3% in Q2 2026, selling an estimated $6.75M and leaving 2,353,300 shares worth $169M. The position accounts for 2.63% of the portfolio, ranked #17.

Ruane, Cunniff & Goldfarb first reported a position in ZTS in Q2 2013 and has held it in 14 quarters since. The position peaked at $287M in Q1 2026. 1,422 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Ruane, Cunniff & Goldfarb held 2,353,300 shares of Zoetis worth $169M as of Q2 2026.
  • Ruane, Cunniff & Goldfarb sold 71,710 Zoetis shares in Q2 2026, an estimated $6.75M.
  • Zoetis made up 2.63% of Ruane, Cunniff & Goldfarb's portfolio in Q2 2026, its #17 holding.
  • Ruane, Cunniff & Goldfarb first reported a position in Zoetis in Q2 2013 and has held it in 14 quarters since.
  • Ruane, Cunniff & Goldfarb's Zoetis position peaked at $287M in Q1 2026.
  • 1,422 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2026, filed 14 Aug 2026.